Top Markets
Coin of the day
OncoCyte Corporation OncoCyte Corporation

OncoCyte Corporation

OCX
Classement en actions #38932
OncoCyte Corporation is a molecular diagnostics firm that conceptualizes,... OncoCyte Corporation is a molecular diagnostics firm that conceptualizes, refines, and brings to market its exclusive laboratory-developed tests aimed at identifying cancer in patients, serving both the United States and global markets. The company's portfolio features DetermaRx, a specialized molecular test for detecting early-stage adenocarcinoma in the lung, alongside DetermaIO, a unique proprietary assay that assesses gene expression. In addition to its diagnostic offerings, OncoCyte provides a suite of services including biomarker discovery, the design and development of new assays, and essential support for clinical trials. It also delivers various biomarker testing solutions specifically tailored for pharmaceutical companies. OncoCyte has established a collaborative agreement with Life Technologies Corporation. This partnership is geared towards the co-development and commercialization of the Oncomine Comprehensive Assay Plus and Determa IO assay, which are designed for use with the Ion Torrent Genexus integrated sequencer and purification system. The corporation was founded in 2009 and its primary base of operations is situated in Irvine, California.
Prix de l'action
$2.84
Dernière synchronisation: 2025-07-14
Capitalisation boursière
$729.71K
Changement (1 jour)
-0.70%
Changement (1 an)
0.00%
Pays
US
Échange OncoCyte Corporation (OCX)

Catégorie

Le prix OCX avec la capitalisation boursière de B
OncoCyte Corporation OncoCyte Corporation
OCX
$2.84
Capitalisation boursière de OncoCyte Corporation(OCX)
Capitalisation boursière: $729.71K
En August 2026, OncoCyte Corporation a une capitalisation boursière de $729.71K. Cela fait de OncoCyte Corporation la 38932nd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de OncoCyte Corporation du 2015 au 2026
OCX par rapport au top 5 des plus populaires stocks
Prix pour OCX L’actif B La capitalisation boursière de B Résultats
OncoCyte Corporation OncoCyte Corporation
$21,287,218 $729.71K
$5.470T +749,549,827.53%
OncoCyte Corporation OncoCyte Corporation
$17,385,659 $729.71K
$4.467T +612,170,988.78%
OncoCyte Corporation OncoCyte Corporation
$16,246,541 $729.71K
$4.174T +572,061,219.52%
OncoCyte Corporation OncoCyte Corporation
$14,400,550 $729.71K
$3.700T +507,061,518.69%
OncoCyte Corporation OncoCyte Corporation
$11,108,985 $729.71K
$2.854T +391,161,356.49%